•
Dec 31, 2023

Stryker Q4 2023 Earnings Report

Stryker reported strong Q4 2023 results, with significant increases in net sales and EPS.

Key Takeaways

Stryker reported an 11.8% increase in net sales to $5.8 billion and a 102.7% increase in EPS to $2.98 for Q4 2023. Organic net sales grew by 11.4%. The company surpassed $20 billion in sales for the full year and expects continued growth in 2024.

Net sales increased by 11.8% to $5.8 billion.

Organic net sales increased by 11.4%.

Reported EPS increased by 102.7% to $2.98.

Adjusted EPS increased by 15.3% to $3.46.

Total Revenue
$5.82B
Previous year: $5.2B
+11.8%
EPS
$3.46
Previous year: $3
+15.3%
Organic Net Sales Growth
11.4%
Previous year: 13.2%
-13.6%
Gross Profit
$3.7B
Previous year: $3.24B
+14.4%
Cash and Equivalents
$2.94B
Previous year: $1.84B
+59.4%
Free Cash Flow
$1.35B
Previous year: $815M
+65.9%
Total Assets
$39.9B
Previous year: $36.9B
+8.1%

Stryker

Stryker

Stryker Revenue by Geographic Location

Forward Guidance

Stryker expects 2024 organic net sales growth to be in the range of 7.5% to 9.0% and adjusted net earnings per diluted share to be in the range of $11.70 to $12.00.

Positive Outlook

  • Momentum from 2023
  • Strong procedural volumes
  • Healthy demand for capital products
  • Stabilizing macro-economic environment
  • Steady progress of pricing actions

Challenges Ahead

  • Sales will be modestly unfavorably impacted by foreign exchange rates for the full year, being more negative in the first half of the year.
  • Adjusted net earnings per diluted share will be negatively impacted by foreign exchange rates approximately $0.05 to $0.10.
  • We are unable to present a quantitative reconciliation of our expected net sales growth to expected organic net sales growth as we are unable to predict with reasonable certainty and without unreasonable effort the impact and timing of acquisitions and divestitures and the impact of foreign currency exchange rates.
  • We are unable to present a quantitative reconciliation of our expected net earnings per diluted share to expected adjusted net earnings per diluted share as we are unable to predict with reasonable certainty and without unreasonable effort the impact and timing of structural optimization and other special charges, acquisition-related expenses and the outcome of certain regulatory, legal and tax matters.
  • The financial impact of these items is uncertain and is dependent on various factors, including timing, and could be material to our Consolidated Statements of Earnings.

Revenue & Expenses

Visualization of income flow from segment revenue to net income